name: Lupus anticoagulant aPTT screening panel


name: Cells.chromosome Y deletion/Cells counted


name: Cells.chromosome region 1p32 deletion/Cells counted


name: Cells.chromosome region 20q12 deletion/Cells counted


name: Hereditary motor neuropathy multigene analysis


name: Hereditary motor and sensory neuropathy multigene analysis


name: Hereditary sensory neuropathy multigene analysis


name: Hereditary spastic paraplegia multigene analysis


name: Hereditary congenital myasthenic syndrome multigene analysis


name: Hereditary emery dreifuss multigene analysis


name: Dyserythropoietic anemia multigene analysis


name: Erythrocytosis focused multigene analysis


name: CYB5 and CYB5 Reductase multigene analysis


name: EBV Lymphoproliferation multigene analysis


name: Dysregulation autoimmune multigene analysis


name: Autoimmune lymphoproliferative syndrome multigene analysis


name: Bacteria Identification and Susceptibility


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1


name: Peripheral neuropathy multigene analysis


name: Information to tell doctors if you have a sudden injury or illness with a good chance of recovery


name: Information to tell the medical team if you stop breathing or your heart stops beating


name: CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.2


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge


name: Information to tell doctors if you experience failing health with a low chance of recovery


name: HISGT Histone genes targeted mutation analysis


name: Multiple sulfatase deficiency enzymes panel


name: Basic metabolic & hemoglobin & hematocrit panel


name: Cosmetic facility registration-abbreviated renewal


name: Cosmetic facility registration-biennial renewal


name: Breast Cancer recurrence risk multigene analysis


name: Feeling down, depressed, irritable, or hopeless in last 2W


name: Poor appetite, weight loss, or overeating in last 2W


name: Mucopolysaccharidosis type II newborn screen interpretation


name: Guanidinoacetate methyltransferase deficiency comment


name: Medication list for public health &or CDC reporting


name: Diagnostic multisection transesophageal & cardioversion panel


name: Multisection transesophageal for congenital disease


name: Views screening for diabetic retinopathy


name: Duration description of condition episode


name: Chronic and low grade B cell lymphoid neoplasm multigene analysis


name: B cell non hodgkin Lymphoma multigene analysis


name: Diagnostic peripheral vascular disease study


name: Oxalate & Glycolate & Glyoxylate & Citrate:Imp:Pt:Urine:Nom


name: Escherichia coli O157:H7 DNA:PrThr:Pt:Wound:Ord:Probe.amp.tar


name: PLA2G7 & PLAC8 gene expression level:Score:Pt:Bld:Qn:Molgen


name: SARS coronavirus 2 Mpro gene mutation detected:Prid:Pt:XXX:Nom:Molgen


name: HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA:PrThr:Pt:Ser/Plas/Bld^Donor:Ord:Probe.amp.tar


name: AAV serotype rh74 Ab:PrThr:Pt:Ser/Plas:Ord:IA


name: Direct antiglobulin test.polyspecific reagent:PrThr:Pt:RBC^Fetus:Ord


name: Staphylococcus aureus MLVA type:Type:Pt:Isolate/Specimen:Nom:Molgen


name: Imatinib ^24H post dose:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS


name: N-Desethyl Sunitinib^24H post dose:MCnc:Pt:Ser/Plas:Qn:LC/MS/MS


name: Hepatitis B virus RNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Coagulation surface induced.lupus sensitive.buffer (LA control):Time:Pt:PPP:Qn:Coag


name: Lupus anticoagulant aPTT screening panel:-:Pt:PPP:-:Coag


name: Small lymphocytic lymphoma chromosome deletions &or rearrangements:Find:Pt:Bld/Tiss:Doc:FISH


name: Enterococcus faecalis+Enterococcus faecium DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Klebsiella pneumoniae + Klebsiella oxytoca DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis:PrThr:Pt:Genital fld:Ord:Probe.amp.tar


name: Coccidioides sp Ab.IgG & IgM:ACnc:Pt:Ser+CSF:Ord:IA


name: Herpes virus 6A DNA:NCnc:Pt:Ser/Plas:Qn:Non-probe.amp.tar


name: Herpes virus 6B DNA:ACnc:Pt:Ser/Plas:Qn:Non-probe.amp.tar


name: Cortisol^2H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Lutropin^10M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^4H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Cells.chromosome Y deletion/Cells counted:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Campylobacter & Salmonella & Shigella sp:Prid:Pt:Stool:Nom:Organism specific culture


name: Campylobacter & Salmonella & Shigella & Yersinia sp:Prid:Pt:Stool:Nom:Organism specific culture


name: Salmonella & Shigella & Campylobacter & E. coli sp:Prid:Pt:Stool:Nom:Organism specific culture


name: Cells.chromosome region 1p32 deletion/Cells counted:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Cells.chromosome region 1q21 duplication:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Soluble triggering receptor expressed on myeloid cells-1:MCnc:Pt:Ser/Plas:Qn:IA


name: Hemiplegic migraine multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CTNNB1 gene targeted mutation analysis:Find:Pt:Tumor:Doc:Molgen


name: TP53 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Gamma aminobutyrate A receptor Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Deprecated Yersinia pestis DNA [Presence] in Blood by NAA with non-probe detection


name: Crimean-Congo hemorrhagic fever virus RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Ebolavirus Bundibugyo+Reston+Sudan+Taï Forest+Zaire RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: West Nile virus RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Yellow fever virus RNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Cells.chromosome region 20q12 deletion/Cells counted:NFr:Pt:Bld/Bone mar:Qn:FISH


name: Hereditary motor neuropathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary motor and sensory neuropathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary sensory neuropathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary spastic paraplegia multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Distal weakness multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary congenital myasthenic syndrome multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary emery dreifuss multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Dyserythropoietic anemia multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: CYB5 and CYB5 Reductase multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: RBC membrane multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: EBV Lymphoproliferation multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hyper igE syndrome multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Dysregulation autoimmune multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Viral Susceptibility multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Autoimmune lymphoproliferative syndrome multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Other cells/100 leukocytes:NFr:Pt:BAL:Qn:Manual count


name: Human papilloma virus 16 & 18+45 mRNA:PrThr:Pt:Anorectal:Ord:Probe.amp.tar


name: Chemokine (C-C motif) ligand 26:MCnc:Pt:Ser/Plas:Qn:IA


name: Monocyte Chemoattractant Proteins 4:MCnc:Pt:Ser/Plas:Qn:IA


name: Influenza A H3N2V RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Bacteria Identification and Susceptibility:Find:Pt:Bld.pos growth:Doc


name: Aeromonas & plesiomonas sp:Prid:Pt:Stool:Nom:Organism specific culture


name: Renal calculus risk assessment:Likelihood:24H:Urine:Nar


name: Tripartite motif containing 46:PrThr:Pt:XXX:Ord:IF


name: HBA1 & HBA2 gene deletion:Find:Pt:Amnio fld/CVS:Doc:Molgen


name: NOTCH3 gene full mutation analysis:Find:Pt:XXX:Doc:Molgen


name: Motor neuron disease multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Muscular dystrophy multigene analysis:Find:Pt:XXX:Doc:Molgen


name: HIF2A gene targeted mutation analysis:Find:Pt:Bld:Doc:Molgen


name: Peripheral neuropathy multigene analysis:Find:Pt:XXX:Doc:Molgen


name: KRAS Somatic mutation analysis:Find:Pt:Tumor:Doc:Molgen


name: Parkinson Disease multigene analysis:Find:Pt:XXX:Doc:Molgen


name: HISGT Histone genes targeted mutation analysis:Find:Pt:Tumor:Doc:Molgen


name: Multiple sulfatase deficiency enzymes panel:-:Pt:WBC:-


name: Basic metabolic & hemoglobin & hematocrit panel:-:Pt:Bld:-


name: Human bocavirus DNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Non-probe.amp.tar


name: Legionella pneumophila DNA:PrThr:Pt:Respiratory system specimen.upper:Ord:Non-probe.amp.tar


name: Cells.CD34 recipient derived/Cells.CD34^post stem cell transplantation:NFr:Pt:Bone mar:Qn:Molgen


name: Breast Cancer recurrence risk multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: Cytokeratin 19 mRNA for cancer metastasis:PrThr:Pt:Lymph node:Ord:Non-probe.amp.tar


name: TRCA+TCRD gene rearrangements:Find:Pt:Bone marrow:Doc:FISH


name: TCL-1A gene rearrangements:Find:Pt:Bone marrow:Doc:FISH


name: Human papilloma virus 31+33+52+58 DNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar


name: Clostridium tetani toxin TeNT gene:PrThr:Pt:XXX:Ord:Non-probe.amp.tar


name: Clostridium tetani toxin TeNT gene:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Clostridium tetani toxin:PrThr:Pt:XXX:Ord:Mouse bioassay.neutralization


name: Clostridium tetani toxin:PrThr:Pt:XXX:Ord:Endopeptidase Assay


name: Clostridium tetani toxin:PrThr:Pt:Ser/Plas:Ord:Endopeptidase Assay


name: Clostridium tetani toxin:PrThr:Pt:Ser/Plas:Ord:Mouse bioassay


name: Mucopolysaccharidosis type II newborn screen interpretation:Imp:Pt:Bld.dot:Nom


name: Mucopolysaccharidosis type II comment:Txt:Pt:Bld.dot:Nar


name: Guanidinoacetate methyltransferase deficiency comment:Txt:Pt:Bld.dot:Nar


name: Immunoglobulin lambda light chain gene 22q11.22 rearrangement:Find:Pt:XXX:Doc:FISH


name: Immunoglobulin kappa light chain gene 2p11.2 rearrangement:Find:Pt:XXX:Doc:FISH


name: CRLF2 gene rearrangements:Find:Pt:Bld/Bone mar:Doc:FISH


name: Chronic and low grade B cell lymphoid neoplasm multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: B cell non hodgkin Lymphoma multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Histiocytic neoplasm multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Plasma cell myeloma multigene analysis:Find:Pt:Bone marrow:Doc:Molgen


name: T cell lymphoma multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^2 umol/L:RelACnc:Pt:Bld:Qn


name: Platelet aggregation.collagen induced^2 ug/mL:RelACnc:Pt:PRP:Qn


name: Fibroblast growth factor 23:PrThr:Pt:Tiss:Ord:FISH


name: Hepatitis A virus cellular receptor 1:Ratio:Pt:Urine:Qn:Calculation


name: IgH & IgK gene rearrangement status:Prid:Pt:XXX:Nom:Molgen


name: Hematopoietic progenitor cells/cells.total:NFr:Pt:Bld:Qn:Automated count


name: ALK gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: MET gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: BRAF gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: ERBB2 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Chromosome 5 & 9 & 15 aneuploidy:Find:Pt:Bone mar:Doc:FISH


name: ROS1 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: KIT gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PDGFRA gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: PDGFRA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Common myeloid progenitor cell:NCnc:Pt:Bld:Qn:VC


name: Common myeloid progenitor cell:NCnt:Pt:Bld:Qn


name: Burst forming unit erythroid:NCnc:Pt:Bld:Qn:VC


name: Burst forming unit erythroid:NCnt:Pt:Bld:Qn


name: CXCR4 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Bacillus anthracis Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Bacillus anthracis Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Bacillus anthracis protective antigen Ab:PrThr:Pt:Ser:Ord:IA


name: Bordetella pertussis Ab.IgA^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Bordetella pertussis Ab.IgA^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Bordetella pertussis.pertussis toxin Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Bordetella pertussis.pertussis toxin Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Borna disease virus RNA:PrThr:Pt:Brain tissue:Ord:Probe.amp.tar


name: Borna disease virus RNA:PrThr:Pt:Brain tissue:Ord:Probe


name: Borna disease virus RNA:PrThr:Pt:Brain tissue:Ord:Sequencing


name: Borna disease virus RNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: Borna disease virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Borna disease virus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Borna disease virus RNA:PrThr:Pt:XXX:Ord:Sequencing


name: Borna disease virus Ag:PrThr:Pt:Brain tissue:Ord:Immune stain


name: Borna disease virus Ag:PrThr:Pt:XXX:Ord:Immune stain


name: Borrelia recurrentis:PrThr:Pt:CSF:Ord:Organism specific culture


name: Borrelia recurrentis:PrThr:Pt:Bld:Ord:Organism specific culture


name: Brucella sp Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Brucella sp Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Chikungunya virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Chlamydophila psittaci Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Chlamydophila psittaci Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Corynebacterium pseudotuberculosis:PrThr:Pt:XXX:Ord:Organism specific culture


name: Corynebacterium pseudotuberculosis:PrThr:Pt:Respiratory system specimen.upper:Ord:Organism specific culture


name: Corynebacterium ulcerans:PrThr:Pt:Respiratory system specimen.upper:Ord:Organism specific culture


name: Coxiella burnetii Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Coxiella burnetii Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Coxiella burnetii Ab.IgM^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Coxiella burnetii Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Dengue virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Dengue virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Dengue virus Ab.IgM^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Ebola virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Ebola virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgA index:ACnc:Pt:Ser+CSF:Qn


name: European tick borne encephalitis virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgM:Titr:Pt:CSF:SemiQn:IA


name: European tick borne encephalitis virus Ab.IgM:Titr:Pt:Ser:SemiQn:IA


name: European tick borne encephalitis virus RNA:PrThr:Pt:CSF:Ord:Probe.amp.tar


name: European tick borne encephalitis virus RNA:PrThr:Pt:Tissue.postmortem:Ord:Probe.amp.tar


name: Francisella tularensis Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Francisella tularensis Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis A virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis A virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis A virus Ab.IgM:Titr:Pt:Ser:SemiQn


name: Hepatitis E virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Hepatitis E virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Lassa virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Lassa virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Legionella sp Ab^1st specimen:Titr:Pt:Ser:Ord:IA


name: Leptospira sp Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Leptospira sp Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Leptospira sp Ab.IgM^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Measles virus Ab.IgG avidity:Ratio:Pt:Ser:SemiQn:IA


name: Middle East respiratory syndrome coronavirus:PrThr:Pt:XXX:Ord:Neut


name: Mycobacterium leprae PGL-1 Ab:Titr:Pt:Ser:SemiQn


name: Norovirus genogroup II Ag:PrThr:Pt:Stool:Ord


name: Polio virus 1 Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Polio virus 1 Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Polio virus 3 Ab^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Polio virus 3 Ab^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Rickettsia prowazekii Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Rickettsia prowazekii Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Rubella virus Ab.IgM index:ACnc:Pt:Ser+CSF:Qn


name: SARS coronavirus 2 RNA:PrThr:Pt:Respiratory System Specimen:Ord


name: Trichinella spiralis Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Trichinella spiralis Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Varicella zoster virus Ab.IgA index:ACnc:Pt:Ser+CSF:Qn


name: Varicella zoster virus Ab.IgA:PrThr:Pt:CSF:Ord:IA


name: Varicella zoster virus Ab.IgG:PrThr:Pt:CSF:Ord:IA


name: Yellow fever virus Ab.IgG:Titr:Pt:Ser:SemiQn:IA


name: Yellow fever virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia enterocolitica O:3 Ab:PrThr:Pt:Stool:Ord


name: Yersinia enterocolitica O:5 Ab:PrThr:Pt:Stool:Ord


name: Yersinia enterocolitica O:8 Ab:PrThr:Pt:Stool:Ord


name: Yersinia enterocolitica O:9 Ab:PrThr:Pt:Stool:Ord


name: Yersinia pestis Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia pestis Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia pseudotuberculosis 2 Ab:PrThr:Pt:Stool:Ord


name: Yersinia pseudotuberculosis 3 Ab:PrThr:Pt:Stool:Ord


name: Zika virus Ab.IgG^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Zika virus Ab.IgG^2nd specimen:Titr:Pt:Ser:SemiQn:IA


name: Follitropin^4H post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Erythrocytosis focused multigene analysis:Find:Pt:XXX:Doc:Sequencing


name: IDH1 & IDH2 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Borrelia recurrentis:PrThr:Pt:XXX:Ord:Organism specific culture


name: Corynebacterium ulcerans:PrThr:Pt:XXX:Ord:Organism specific culture


name: Dengue virus Ab.IgM^1st specimen:Titr:Pt:Ser:SemiQn:IA


name: Yersinia pseudotuberculosis 1 Ab:PrThr:Pt:Stool:Ord


name: HL7 Standardization Medication Profile (SMP)


name: Transfer to same level Intensive Care Unit


name: Transfer to more specialized Intensive Care Unit ( ICU)


name: Thorater percutaneous ventricular assist device (PVAD)


name: CentriMag acute mechanical circulatory support system


name: Tandem Heart Percutaneous Ventricular Assist Device


name: Go to any other place or event not mentioned


name: History and physical note:Find:Pt:{Setting}:Doc:Rapid response team


name: Surgical operation note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: Consultation note:Find:Pt:Outpatient:Doc:Physical medicine and rehab


name: Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:General medicine


name: Study observation^W fluorescein IV:Find:Pt:Ocular fundus:Nom:Angiography


name: Cosmetic product listing:-:-:^FDA package insert:Nar


name: Cosmetic facility registration:-:-:^FDA package insert:Nar


name: Comprehensive foot screening report:Find:Pt:^Patient:Doc


name: Retinal eye screening report:Find:Pt:^Patient:Doc


name: Brief interview for mental status:-:RptPeriod:^Patient:-:CMS Assessment


name: Repetition of three words:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Temporal orientation - current year:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Temporal orientation - current month:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Recall - sock:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Recall - blue:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Recall - bed:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Temporal orientation (orientation to year, month, and day):-:RptPeriod:^Patient:-:CMS Assessment


name: Temporal orientation - current day of the week:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Brief interview for mental status - summary score:Score:RptPeriod:^Patient:Qn:CMS Assessment


name: Mood interview total severity score:Score:RptPeriod:^Patient:Qn:CMS Assessment


name: Staff assessment of resident mood (PHQ-9-OV):-:RptPeriod:^Patient:-:CMS Assessment


name: Staff assessment of resident mood total severity score:Score:RptPeriod:^Patient:Qn:CMS Assessment


name: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Mental health directive form:Find:Pt:{Setting}:Doc:Mental health


name: Annual evaluation note:Find:Pt:{Setting}:Doc:Mental health


name: Note:Find:Pt:Outpatient:Doc:Child and adolescent psychiatry


name: Patient state index:Score:Pt:Cerebral cortex:Qn:EEG


name: Study observation:Find:Pt:Lower GI tract:Nar:CT


name: Pneumonia probability:Likelihood:Pt:^Patient:Qn:Artificial intelligence based calculation


name: Medication Management Note:Find:Pt:{Setting}:Doc:Bone marrow transplant


name: Medication Management Note:Find:Pt:{Setting}:Doc:Cardiovascular disease


name: Medication Management Note:Find:Pt:{Setting}:Doc:Critical Care Medicine


name: Medication Management Note:Find:Pt:{Setting}:Doc:Emergency medicine


name: Medication Management Note:Find:Pt:{Setting}:Doc:Geriatric medicine


name: Medication Management Note:Find:Pt:{Setting}:Doc:Infectious disease


name: Medication Management Note:Find:Pt:Long term care facility:Doc


name: Views^W contrast IT:Find:Pt:Abdomen>Spine.lumbar & Pelvis>Sacrum:Doc:RF


name: Guidance for removal of foreign body:Find:Pt:Chest>Esophagus:Doc:RF


name: Views^W contrast via nephrostomy tube:Find:Pt:Abdomen>Kidney:Doc:RF


name: Views^W contrast retrograde via urethra:Find:Pt:Pelvis>Urethra:Doc:RF


name: Guidance for angioplasty^W contrast:Find:Pt:Extremity>Extremity vessels.bilateral:Doc:RF.angio


name: Guidance for angioplasty^W contrast:Find:Pt:Extremity>Extremity vessels.left:Doc:RF.angio


name: Guidance for angioplasty^W contrast:Find:Pt:Extremity>Extremity vessels.right:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Carotid artery.internal.bilateral:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Vertebral vessels.left:Doc:RF.angio


name: Views^W contrast IA:Find:Pt:Head+Neck>Vertebral vessels.right:Doc:RF.angio


name: Views GE 2 && Views:Find:Pt:Chest:Doc:XR && RF


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Abdomen+Pelvis:Doc:CT


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Abdomen:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Facial bones:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head>Sella turcica+Orbit:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Lower leg:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Sella turcica+Orbit:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head>Sella turcica+Orbit.bilateral:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Sella turcica+Orbit.bilateral:Doc:CT


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Pelvis:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Upper extremity.bilateral>Forearm:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Forearm:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Ankle:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Head>Mastoid:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Foot:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Wrist:Doc:CT


name: Views screening for implant:Find:Pt:Breast.left:Doc:MG


name: Views screening for implant:Find:Pt:Breast.right:Doc:MG


name: View^W contrast intra duct:Find:Pt:Breast>Breast duct.bilateral:Doc:MG


name: Guidance for needle localization:Find:Pt:Breast:Doc:MG


name: Views screening for implant:Find:Pt:Breast:Doc:MG


name: Views diagnostic for implant:Find:Pt:Breast:Doc:MG


name: Multisection limited:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:US.doppler


name: Multisection:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior:Doc:US.doppler


name: Multisection limited:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior:Doc:US.doppler


name: Multisection limited:Find:Pt:Lower extremity.left>Lower extremity vein:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.right>Lower extremity vein:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.left>Lower extremity artery:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.right>Lower extremity artery:Doc:US


name: Multisection limited:Find:Pt:Lower extremity.left>Lower extremity artery:Doc:US.doppler


name: Multisection limited:Find:Pt:Lower extremity.right>Lower extremity artery:Doc:US.doppler


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1:-:RptPeriod:^Patient:-:CMS Assessment


name: Rehabilitation progress note:Find:Pt:{Setting}:Doc:Cardiovascular disease


name: Ectopic pregnancy &or abortion:Num:Pt:^Patient:Qn:Reported


name: Information to tell doctors if you have a sudden injury or illness with a good chance of recovery:Find:Pt:^Patient:Nar:Reported


name: Information to tell the medical team if you stop breathing or your heart stops beating:Find:Pt:^Patient:Nar:Reported


name: CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.2:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: Ultrasound for pregnancy in third trimester:Find:Pt:^Mother:Nom


name: Information to tell doctors if you experience failing health with a low chance of recovery:Find:Pt:^Patient:Nar:Reported


name: Ultrasound for pregnancy in second trimester:Find:Pt:^Mother:Nom


name: Intensive Care Unit specialty destination:Type:Pt:^Patient:Nom


name: Multisection^W contrast IV && Multisection^WO & W contrast IV:Find:Pt:Head && Neck:Doc:CT.angio && CT.angio


name: Cosmetic facility registration:-:-:^FDA product label:Nar


name: Cosmetic facility registration-amendment:-:-:^FDA product label:Nar


name: Cosmetic facility registration-abbreviated renewal:-:-:^FDA product label:Nar


name: Cosmetic facility registration-cancellation:-:-:^FDA product label:Nar


name: Cosmetic facility registration-biennial renewal:-:-:^FDA product label:Nar


name: Cosmetic-abbreviated renewal:-:-:^FDA product label:Nar


name: Animal drug for further processing:-:-:^FDA product label:Nar


name: Alive and without mechanical ventilation:Score:4W:^Patient:Qn:Reported


name: Alive and without mechanical ventilation:Score:2M:^Patient:Qn:Reported


name: Alive and without mechanical ventilation:Score:3W:^Patient:Qn:Reported


name: History and physical note:Find:Pt:{Setting}:Doc:Vascular Access


name: Group counseling note:Find:Pt:{Setting}:Doc:Child Life


name: View for salivary calculus:Find:Pt:Head>Salivary gland:Doc:XR


name: View for salivary calculus:Find:Pt:Head>Salivary gland.bilateral:Doc:XR


name: View for salivary calculus:Find:Pt:Head>Salivary gland.right:Doc:XR


name: View for salivary calculus:Find:Pt:Head>Salivary gland.left:Doc:XR


name: Feeling down, depressed, irritable, or hopeless in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Little interest or pleasure in doing things in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Poor appetite, weight loss, or overeating in last 2W:Find:2W:^Patient:Ord:Reported.PHQ


name: Trouble concentrating on things like school work, reading, or watching TV in last 2W:Find:2W:^Patient:Ord


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A3C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calculed by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.3D.A2C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.3D.A3C+Calculated by biplane method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.3D.A4C+Calculated by biplane method


name: Longitudinal strain.max:LenRto:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by triplane method


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calculated by biplane area-length method


name: Orifice area/Body surface area:ArArea:Pt:Aortic valve:Qn:US.2D


name: Maternal condition that affected the fetus:Find:Pt:^Mother:Nom


name: Secondary cause of death:Find:Pt:^Fetus:Nom


name: Disease onset to death interval:Time:Pt:^Patient:Qn


name: Ultrasound for pregnancy in first trimester:Find:Pt:^Mother:Nom


name: Patient generated medication list:ID:Episode:Pharmacy:Nom


name: Medication list for public health &or CDC reporting:ID:Episode:Pharmacy:Nom


name: Multisection transesophageal for congenital disease^W agitated saline IV:Find:Pt:Chest>Heart:Doc:US


name: Views screening for diabetic retinopathy:Find:Pt:Eye.left:Doc:{Imaging modality}


name: Views screening for diabetic retinopathy:Find:Pt:Eye.right:Doc:{Imaging modality}


name: Views^post radioactive seed localization:Find:Pt:Breast.left:Doc:MG.stereotactic


name: Views^post radioactive seed localization:Find:Pt:Breast.right:Doc:MG.stereotactic


name: Duration description of condition episode:Find:Pt:^Patient:Ord:Reported


name: US.doppler|Lower extremity artery|Multisection limited|Laterality:ANY


name: US|Lower extremity artery|Multisection limited|Laterality:ANY


name: US|Lower extremity vein|Multisection limited|Laterality:ANY


name: MG.stereotactic|Breast|Views^post radioactive seed localization|Laterality:ANY


name: MG|Breast|Views screening for implant|Laterality:ANY


name: 10 minutes post dose gonadotropin releasing hormone


name: Platelet aggregation collagen induced 2 ug/mL


name: Platelet aggregation.adenosine diphosphate induced ATP secretion^2 umol/L


name: Cells.CD34 recipient derived/Cells.CD34^post stem cell transplantation


name: Views^post radioactive seed localization


name: Multisection transesophageal for congenital disease^W agitated saline IV


name: US.2D.A2C+Calculated by biplane area-length method


name: US.3D.A4C+Calculated by biplane area-length method


name: US.2D.A4C+Calculated by biplane area-length method


name: US.2D+Calculated by average triplane method


name: Artificial intelligence based calculation


name: Amoxicillin+Clavulanate | Isolate.UTI | Antibiotic susceptibilities


name: Aldosterone/Renin | Serum or Plasma | Chemistry - non-challenge


name: Creatine/Creatinine | DBS | Chemistry - non-challenge


name: Guanidinoacetate/Creatinine | DBS | Chemistry - non-challenge


name: Mucopolysaccharidosis type II newborn screen interpretation | DBS | Chemistry - non-challenge


name: Mucopolysaccharidosis type II comment | DBS | Chemistry - non-challenge


name: Iohexol disappearance panel | Urine and Serum or Plasma | Chemistry Panels


name: Immunoglobulins and heavy-light chain panel | Serum or Plasma | Chemistry Panels


name: External Steroid panel | Serum or Plasma | Chemistry Panels


name: Eszopiclone and Zopiclone | Urine | Drug toxicology


name: Ethanol cutoff | Exhaled gas | Drug toxicology


name: Coagulation surface induced.lupus sensitive.buffer (LA control) | Platelet poor plasma | Coagulation


name: Horse dander IgE panel | Serum or Plasma | Allergy Panels


name: Cat epithelium IgE panel | Serum or Plasma | Allergy Panels


name: Dog dander IgE panel | Serum or Plasma | Allergy Panels


name: Direct antiglobulin test.polyspecific reagent | Fetus | Blood bank


name: Direct antiglobulin test.polyspecific reagent | Fetus | Red Blood Cells | Blood bank


name: ABO group and Rh Type and Atypical Ab Panel


name: ABO group and Rh Type and Atypical Ab Panel | Serum, Plasma or Blood | Blood Bank Panels


name: Additional treatment | Urine | Fertility testing


name: Erythrocytosis multigene analysis | XXX | Molecular pathology


name: Erythrocytosis focused multigene analysis | XXX | Molecular pathology


name: EBV Lymphoproliferation multigene analysis | Blood or Tissue | Molecular pathology


name: Dysregulation autoimmune multigene analysis | XXX | Molecular pathology


name: Dyserythropoietic anemia multigene analysis | XXX | Molecular pathology


name: Distal weakness multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary spastic paraplegia multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary sensory neuropathy multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary Motor Neuropathy multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary motor and sensory neuropathy multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary emery dreifuss multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary congenital myasthenic syndrome multigene analysis | Blood or Tissue | Molecular pathology


name: HMEP-Hemiplegic migraine multigene analysis | Blood or Tissue | Molecular pathology


name: Hyper igE syndrome multigene analysis | XXX | Molecular pathology


name: Histiocytic neoplasm multigene analysis | Blood or Tissue | Molecular pathology


name: Plasma cell myeloma multigene analysis | Bone marrow | Molecular pathology


name: T cell lymphoma multigene analysis | Blood or Tissue | Molecular pathology


name: RBC membrane multigene analysis | XXX | Molecular pathology


name: CTNNB1 gene targeted mutation analysis | Tumor | Molecular pathology


name: CYB5 and CYB5 Reductase multigene analysis | XXX | Molecular pathology


name: KRAS Somatic mutation analysis | Tumor | Mutations


name: Viral Susceptibility multigene analysis | XXX | Molecular pathology


name: Autoimmune lymphoproliferative syndrome multigene analysis | XXX | Molecular pathology


name: B cell non hodgkin Lymphoma multigene analysis | Blood or Tissue | Molecular pathology


name: Chronic and low grade B cell lymphoid neoplasm multigene analysis | Blood or Tissue | Molecular pathology


name: Metagenomic DNA and RNA Sequencing | Cerebral spinal fluid | Molecular pathology


name: Discharge instructions | Outpatient | Document ontology


name: Instructions | Outpatient | Document ontology


name: End-systolic volume/Body surface area | Heart ventricle - left | Specific hemodynamics


name: US.3D.A2C+Calculated by biplane area-length method


name: Ladd procedure for correction of volvulus


name: Ciliary body destruction; cyclophotocoagulation, transscleral


name: removal of subcutaneous implantable cardioverter-defibrillator electrode


name: Amputation by disarticulation of hindfoot (procedure)


name: Dilation and manipulation of intestinal stoma (procedure)


name: Removal of transvenous pacemaker electrode(s); single lead system, atrial or ventricular


name: Surgical construction of arteriovenous shunt


name: Marsupialization of ranula of salivary gland


name: Detailed new in-facility 45 minutes with ICD diagnosis


name: CASTOR OIL 100 g in 100 mL TOPICAL OIL [Jamaican Black Castor Oil]


name: negative regulation by virus of host cytokine production


name: negative regulation by virus of intracellular interferon activity


name: attenuation of antimicrobial humoral response


name: administrative information regarding test substance


name: Grams per cubic centimeter (qualifier value)


name: negative regulation of neural plate formation


name: syncytium formation induced by viral infection


name: negative regulation of fertilization involved in egg activation


name: negative regulation by virus of host type I interferon production


name: negative regulation by virus of host type I interferon-mediated signaling pathway


name: inhibition by virus of host JAK-STAT cascade


name: suppression by virus of tyrosine phosphorylation of host STAT protein


name: viral inhibition of tyrosine phosphorylation of host STAT protein


name: inhibition of host JAK activity by virus


name: negative regulation by virus of host autophagy


name: negative regulation by virus of host mRNA nuclear export


name: regulation by virus of host chromatin organization


name: suppression by virus of host TRAF-mediated signal transduction


name: suppression by virus of host RIG-I activity


name: inhibition of defense response to bacterium


name: inhibition of host interferon regulatory factor-7 by virus


name: inhibition by virus of host STAT1 activity


name: inhibition by virus of host STAT2 activity


name: inhibition of host mitotic exit by virus


name: viral inhibition of host peptidoglycan biosynthesis


name: protection by virus against host NK cell cytotoxicity


name: suppression by virus of host natural killer cell function


name: down regulation of release of virus from host


name: activation of host reticulophagy by virus


name: negative regulation by virus of host type II interferon-mediated signaling pathway


name: negative regulation by virus of host type III interferon-mediated signaling pathway


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 120 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Moisturizing Sunscreen SPF 50]


name: Using the provided nutritional label how many calories would be consumed if the ate 2 cups of food


name: AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 6 g in 100 mL TOPICAL CREAM [DR LAURANNE]


name: OCTINOXATE 0.91 g in 14 g / TITANIUM DIOXIDE 0.7168 g in 14 g / OCTOCRYLENE 0.42 g in 14 g TOPICAL CREAM [AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 31 TAN]


name: HOMOSALATE 8 g in 100 g / OCTOCRYLENE 4 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL GEL [KIZO LAB UV DEFENSE CLEAR SUNSCREN SPF50]


name: TITANIUM DIOXIDE 0.7168 g in 14 g / OCTOCRYLENE 0.42 g in 14 g / OCTINOXATE 0.91 g in 14 g TOPICAL CREAM [AGE 20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 27 MEDIUM]


name: TITANIUM DIOXIDE 6.8 g in 100 g / ZINC OXIDE 8.5 g in 100 g TOPICAL CREAM [BB Tint 30 BS SPF 30]


name: ZINC OXIDE 0.25 g in 100 g TOPICAL LOTION [Sunscreen In The Raw]


name: ZINC OXIDE 11.2 g in 896 g / OCTINOXATE 63 g in 896 g / OCTISALATE 9 g in 896 g / TITANIUM DIOXIDE 11.2 g in 896 g TOPICAL LOTION [SunStation USA SPF-30 SPORT SUNSCREEN]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 16 g in 100 g TOPICAL STICK [Mens Collection Antiperspirant Deodorant Graphite]


name: NIACINAMIDE 0.04 g in 100 mL TOPICAL CREAM [AUTOPHAGY REVOLUTIONCREAM]


name: NIACINAMIDE 0.04 g in 100 mL TOPICAL CREAM [IDA NESCREAM]


name: OCTINOXATE 75 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL LIPSTICK [Arizona Sun Prickly Pear Lip Balm SPF 15]


name: ZINC OXIDE 18.1 g in 100 g TOPICAL CREAM [Daily Prevention Pure Mineral Hydrating Moisturizer SPF30]


name: HOMOSALATE 6 g in 100 mL / OCTISALATE 5 g in 100 mL / ZINC OXIDE 12 g in 100 mL TOPICAL SOLUTION/ DROPS [Bronzing Blendrops Broad Spectrum SPF 40]


name: OCTISALATE 2.5 g in 50 mL / AVOBENZONE 1.5 g in 50 mL / OCTOCRYLENE 4.35 g in 50 mL / HOMOSALATE 3.65 g in 50 mL TOPICAL CREAM [Olivia and Allison AQUA SKIN SUNSCREEN]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Ageless UV Sheer Defense Mineral Enhanced Sunscreen Broad Spectrum SPF 25]


name: OCTISALATE 4.5 g in 50 mL / HOMOSALATE 9 g in 50 mL / AVOBENZONE 2.7 g in 50 mL / OCTOCRYLENE 9 g in 50 mL TOPICAL CREAM [belif The true cream aqua bomb sunscreen Broad Spectrum SPF 45]


name: TITANIUM DIOXIDE 7.75 g in 100 mL / ZINC OXIDE 10 g in 100 mL TOPICAL CREAM [Ageless UV Tinted Defense Mineral Sunscreen Broad Spectrum SPF30]


name: AVOBENZONE 1.25 g in 50 mL / HOMOSALATE 4.5 g in 50 mL / OCTISALATE 2.25 g in 50 mL / OCTOCRYLENE 4.5 g in 50 mL TOPICAL CREAM [IOPE UV DEFENSE SUN PROTECTOR]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL LOTION [Clear Choise Sunscreen Broad Spectrum SPF 30 Water Resistant Cover Shield]


name: HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 70 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL SPRAY [Sunscreen SPF 30]


name: OCTINOXATE 7.4 g in 100 g / HOMOSALATE 6.2 g in 100 g / OCTISALATE 5.0 g in 100 g / OXYBENZONE 3.1 g in 100 g / AVOBENZONE 1.5 g in 100 g TOPICAL CREAM [Introstem Vitiscell Facial Shield]


name: OCTOCRYLENE 3 g in 100 g / HOMOSALATE 3 g in 100 g / AVOBENZONE 1.5 g in 100 g / OCTISALATE 1 g in 100 g TOPICAL AEROSOL, SPRAY [HAWAIIAN TROPIC]


name: ZINC OXIDE 140 mg in 1 mL TOPICAL CREAM [Lucin Organics Tinted Sunscreen SPF 30 Non Nano Zinc Oxide]


name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Thrive Daily Defense Sunscreen Balm SPF30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [Sunscreen SPF50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [SPF 50 Sunscreen]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 17 g in 100 g TOPICAL GEL [Gillette ClearShield Cool Wave Clear]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Brut Signature Anti-Perspirant and Deodorant]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 120 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL SPRAY [Sunscreen SPF 50]


name: 4-BUTYLRESORCINOL 5 g in 100 mL / TOCOPHEROL 3 g in 100 mL / NIACINAMIDE 3 g in 100 mL / ARBUTIN 7 g in 100 mL TOPICAL CREAM [DRUGGIST PRO DARK SPOT CORRWXTOR]


name: Summer's Eve Sensitive Daily Gentle Cloths


name: Summer's Eve Ultimate Odor Protection Spray


name: Summer's Eve Ultimate Odor Protection Wipes


name: Summers's Eve Ultimate Odor Protection Wash


name: Unifine Protect Safety Pen Needle, 4mmx32G


name: Unifine Protect Safety Pen Needle, 5mmx30G


name: Unifine Protect Safety Pen Needle, 8mmx30G


name: TITANIUM DIOXIDE 5.6 mg in 100 mL / ZINC OXIDE 11 mg in 100 mL TOPICAL CREAM [TINTED FACIAL SUNSCREEN]


name: ARBUTIN 70 mg in 1 g / 4-BUTYLRESORCINOL 50 mg in 1 g / PEG-9 DIGLYCIDYL ETHER/SODIUM HYALURONATE CROSSPOLYMER 30 mg in 1 g / NIACINAMIDE 30 mg in 1 g TOPICAL CREAM [DRUGGIST RETINOL FACE Anti-wrinkle HYALURONIC COMPLEX]


name: ASCORBIC ACID 30 mg in 1 g / KOJIC ACID 20 mg in 1 g / DIGLYCOLIC ACID 20 mg in 1 g / RETINOL 50 mg in 1 g TOPICAL CREAM [DRUGGIST DARK SPOT CORRECTOR]


name: ZINC OXIDE 23.5 g in 100 g TOPICAL CREAM [Thrive Bodyshield 50 SPF 50]


name: CATHETER,INTERMITTENT COUDE 12FR CURE #ULTRAM12C


name: TRACHEOSTOMY TUBE HOLDER PEPPER MEDICAL #504


name: BAG,ENTERAL DRAINAGE SET ENFIT #VED-010EO


name: CATHERIZATION SET,FOLEY W/ CATH 16FR 5ML BARD #A303416A


name: DRESSING,BIATAIN SILICONE ADHESIVE FOAM 3IN X 3IN


name: DRESSING,GEL FIBER SILVER 8IN X 12IN MC#177812


name: CATHETER,INTERMITTENT 10FR FEMALE CURE #F10


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #20104


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #20114


name: TRACHEAL SUCTION SET SZ 7 SMITH #101875070


name: TUBE FEEDING SET,EXTENSION MEDLINE #ENFIT24S


name: DRESSING,CONVAMAX SUPERABSORBER 4IN X 4IN


name: TRACH TUBE,SZ 7 CUFFLESS AIR-LON #1050158


name: DRESSING,ECLYPSE CONTOUR SUPER ABSORBENT #CR4398


name: CATHETER,FOLEY 3-WAY 20FR 30ML BARD #2557H20


name: CATHETER,INTERMITTENT 12FR CURE #ULTRAM12


name: AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL / HOMOSALATE 9 g in 100 mL / OCTOCRYLENE 9 g in 100 mL TOPICAL STICK [Unseen Sunscreen Lip Protector SPF 30]


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / ZINC OXIDE 40 mg in 1 mL TOPICAL CREAM [TROPICAL OTTERS Glitter Sunscreen SPF-50 - Fragrance Free]


name: HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g / OCTOCRYLENE 8 g in 100 g TOPICAL SPRAY [Dermachange SPF 30 Sunscreen]


name: 4-BUTYLRESORCINOL 5 mg in 1 g / NIACINAMIDE 30 mg in 1 g / ARBUTIN 70 mg in 1 g TOPICAL CREAM [DRUGGIST DARK SPOT CORRWXTOR LNTIMATE AREA]


name: 4-BUTYLRESORCINOL 50 mg in 1 g / NIACINAMIDE 30 mg in 1 g / ARBUTIN 70 mg in 1 g TOPICAL CREAM [DRUGGIST INTIMATE DARK SPOT CORRWXTOR]


name: ARBUTIN 70 mg in 1 g / 4-BUTYLRESORCINOL 50 mg in 1 g / NIACINAMIDE 30 mg in 1 g TOPICAL CREAM [DRUGGIST DARK SPOT ARBUTIN CORRWXTOR]


name: ARGININE 30 mg in 1 g / CENTELLA ASIATICA LEAF 50 mg in 1 g TOPICAL CREAM [DRUGGIST SKIN FOOD]


name: ARGININE 30 mg in 1 g / GLYCERIN 70 mg in 1 g TOPICAL CREAM [DRUGGIST CALMING DAY]


name: ASCORBIC ACID 50 mg in 1 g / ARBUTIN 70 mg in 1 g / NIACINAMIDE 70 mg in 1 g / DIGLYCOLIC ACID 50 mg in 1 g / 4-BUTYLRESORCINOL 70 mg in 1 g / KOJIC ACID 70 mg in 1 g / RETINOL 50 mg in 1 g TOPICAL CREAM [DRUGGIST DARK SPOT CORRWXTOR]


name: GLYCERIN 70 mg in 1 g / ARGININE 30 mg in 1 g / CALENDULA OFFICINALIS FLOWERING TOP 50 mg in 1 g TOPICAL CREAM [BULUBIU GOLDEN HOUR RECOVERY]


name: GLYCERIN 70 mg in 1 g / ARGININE 30 mg in 1 g / TOCOPHEROL 30 mg in 1 g / BAKUCHIOL 70 mg in 1 g TOPICAL CREAM [DRUGGIST FIRMING MOISTURIZING]


name: GLYCERIN 70 mg in 1 g / ARGININE 30 mg in 1 g / TOCOPHEROL 30 mg in 1 g TOPICAL CREAM [DAILY FACIAL MOISTURIZER]


name: GLYCERIN 70 mg in 1 g / ARGININE 30 mg in 1 g / TOCOPHEROL 30 mg in 1 g TOPICAL CREAM [DRUGGIST THE tRUE MOISTURIZING BOMB]


name: HYALURONIC ACID 70 mg in 1 g / DIGLYCERIN 70 mg in 1 g / ARGININE 30 mg in 1 g / RETINOL 30 mg in 1 g TOPICAL CREAM [DRUGGIST ANTI-AGING COLLAGEN RETINOL]


name: HYDROLYZED BOVINE ELASTIN (BASE; 1000 MW) 30 mg in 1 g / ARGININE 3 mg in 1 g / HYALURONIC ACID 3 mg in 1 g TOPICAL CREAM [DRUGGIST WEIGHTLESS HYDRATION]


name: HYDROLYZED ORYZANOL 50 mg in 1 g / ALOE PERRYI LEAF 50 mg in 1 g / ARGININE 30 mg in 1 g TOPICAL CREAM [DRUGGIST HONEY HALO]


name: KOJIC ACID 70 mg in 1 g / NIACINAMIDE 70 mg in 1 g / ARBUTIN 70 mg in 1 g TOPICAL CREAM [DRUGGIST SUPER C]


name: NIACINAMIDE 30 mg in 1 g / 4-BUTYLRESORCINOL 50 mg in 1 g / ARBUTIN 70 mg in 1 g TOPICAL CREAM [DRUGGIST COCOA BUTTER]


name: RETINOL 30 mg in 1 g / ARGININE 30 mg in 1 g / HYALURONIC ACID 50 mg in 1 g / GLYCERIN 70 mg in 1 g TOPICAL CREAM [COLLAGEN RETINOL MOISTURIZER FACE]


name: SQUALANE 50 mg in 1 g / ARGININE 30 mg in 1 g TOPICAL CREAM [A I C D FACE CARE]


name: TOCOPHEROL 30 mg in 1 g / ARBUTIN 70 mg in 1 g / 4-BUTYLRESORCINOL 50 mg in 1 g / NIACINAMIDE 30 mg in 1 g TOPICAL CREAM [DRUGGIST VISIBLE RESULT DARK SPOT]


name: TOCOPHEROL 30 mg in 1 g / ARGININE 30 mg in 1 g / GLYCERIN 70 mg in 1 g TOPICAL CREAM [DRUGGIST MOISTURIZING]


name: TRANEXAMIC ACID 3 mg in 1 g / HYDROLYSED BOVINE COLLAGEN (ENZYMATIC; 2000-5000 MW) 30 mg in 1 g / NIACINAMIDE 50 mg in 1 g TOPICAL CREAM [DRUGGIST DARK SPOT FACE BODY CORRWXTOR]


name: TRANEXAMIC ACID 30 mg in 1 g / NIACINAMIDE 50 mg in 1 g TOPICAL CREAM [DARK SPOT CORRWXTOR FOR All SKIN TYPE]


name: glycerin/mineral oil/polycarbophil VAGINAL GEL (GRAM)


name: hyaluronic acid ester 0.2 % VAGINAL GEL WITH APPLICATOR (GRAM)


name: insulin pump cart,automated dosing,BT,G6/G7 with controller SUBCUT EACH


name: insulin pump cartridge,subcut automated dosing,BT,G6/G7 SUBCUT CARTRIDGE (EA)


name: pen needle, diabetic disposable, safety 31 gauge X 3/16" MISCELL NEEDLE, DISPOSABLE


name: CarePoint 1mL 25G 0.625inch Luer Slip Syringe with Needle


name: CarePoint PRECISION 60mL Catheter Tip Syringe


name: CarePoint PRECISION 60mL Luer Slip Syringe without Needle


name: ReliOn 0.3mL 31G 5/16 inch Insulin Syringe


name: ReliOn 0.5mL 31G 15/64 inch Insulin Syringe


name: ReliOn 1mL 31G 15/64 inch Insulin Syringe


name: CarePoint PRECISION 18G 1 inch Poly-Hub Hypodermic Needle


name: CarePoint PRECISION 18G 1-1/2 inch Poly-Hub Hypodermic Needle


name: CarePoint PRECISION 22G 1-1/2 inch Poly-Hub Hypodermic Needle


name: CarePoint PRECISION 23G 1-1/2 inch Poly-Hub Hypodermic Needle


name: CarePoint PRECISION 25G 0.625 inch Poly-Hub Hypodermic Needle


name: CarePoint PRECISION 25G 1 inch Poly-Hub Hypodermic Needle


name: CarePoint PRECISION 27G 0.5 inch Poy-Hub Hypodermic Needle


name: CarePoint PRECISION 30G 0.5 inch Poly-Hub Hypodermic Needle


name: CarePoint SAFETY 23G 1 inch Safety Needle


name: CarePoint SAFETY 23G 1-1/2 inch Safety Needle


name: CarePoint SAFETY 25G x 1 inch Safety Needle


name: CarePoint SAFETY 25G x 1-1/2 inch Safety Needle


name: CarePoint SAFETY 25G x 5/8 inch Safety Needle


name: AeroVent Plus Collapsible Holding Chamber


name: BREATHERITE MDI Spacer with Large Child Mask


name: BREATHERITE MDI Spacer with Neonate Mask


name: BREATHERITE MDI Spacer with Small Child Mask


name: Fora Test N'GO Adv. Mobile Blood Glucose + B-Ketone Monitoring System


name: InnoSpire Deluxe Compressor Nebulizer System


name: InnoSpire Elegance Compressor Nebulizer System


name: InnoSpire Essence Compressor Nebulizer System


name: PuraPly Antimicrobial Wound Matrix (3.02cmx3.02cm)


name: Silicone;Solution, Multi Ingredient NA Multiple Routes Kit


name: Verifine 4mm 32G 5/32 inch Insulin Pen Needle


name: Verifine 5mm 31G 3/16 inch Insulin Pen Needle


name: Verifine 6mm 32G 1/4 inch Insulin Pen Needle


name: Verifine 8mm 31G 5/16 inch Insulin Pen Needle


name: Willis the Wale Pediatric Compressor Nebulizer


name: AVOBENZONE 10 mg in 1 g / OCTISALATE 10 mg in 1 g / OCTINOXATE 65 mg in 1 g / OXYBENZONE 10 mg in 1 g TOPICAL LOTION [Arizona Sun Sunscreen SPF 8]


name: AVOBENZONE 2.9 g in 100 mL / OCTISALATE 4.9 g in 100 mL / OCTOCRYLENE 7.6 g in 100 mL TOPICAL LIQUID [Drops]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 5 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL SPRAY [Kopari Sunglaze Sheer Body Mist Sunscreen SPF42]


name: ZINC OXIDE 20.5 g in 100 mL TOPICAL LOTION [Mineral Shake]


name: ZINC OXIDE 23 g in 100 g TOPICAL CREAM [BOB Kids Sun Balm SPF 40]


name: Spray, Multi Ingredient Topical application Spray [SUMMER'S EVE ULTIMATE REFRESHENING]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE DAILY REFRESHING CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE ULTIMATE DAILY REFRESHING CLOTHS]


name: Solution, Multi Ingredient Topical application Solution [FOSTER&THRIVE ULTRA PESTICIDE FREE LICE TREATMENT]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE DAILY GENTLE CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [SUMMER'S EVE SIMPLY SENSITIVE CLOTHS]


name: Solution, Multi Ingredient Topical application Pad [MONISTAT MAINTAIN FEMININE CLEANSING]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-10%-5%-10% Topical application Lotion [EUCERIN OIL CONTROL SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-7%-4.5%-8% Topical application Lotion [EUCERIN ADVANCED HYDRATION SUNSCREEN]


name: Cream, Multi Ingredient Topical application Cream [FRUIT OF THE EARTH VITAMIN E]


name: Cream, Multi Ingredient Topical application Cream [MANUKA HONEY]


name: Douche, Multi Ingredient Vaginal Solution [SUMMER'S EVE COMPLETE CLEAN DOUCHE]


name: Lubricant Topical application Solution [LUBRICATING LIQUID]


name: insulin pump cartridge, cont auto dosing,BT, G6/G7


name: TITANIUM DIOXIDE 100 mg in 1 g CUTANEOUS LOTION


name: TITANIUM DIOXIDE 4.5 g in 100 mL / ZINC OXIDE 3.4 g in 100 mL TOPICAL OIL [Brush On Block Sun Shine SPF 30 Protective Lip Oil Coral]


name: TITANIUM DIOXIDE 6.8 g in 100 g / ZINC OXIDE 8.5 g in 100 g TOPICAL CREAM [BB Bronze 30 BS SPF30]


name: ZINC OXIDE 22.973 g in 100 g TOPICAL LOTION [Mary Kay Mineral Facial Sunscreen Broad Spectrum SPF30]


name: ZINC OXIDE 8.5 g in 100 g / TITANIUM DIOXIDE 6.8 g in 100 g TOPICAL CREAM [BB Brite 30 BS SPF30]


name: AVOBENZONE 2.9 g in 100 g / HOMOSALATE 6.9 g in 100 g / OCTISALATE 4.9 g in 100 g / OCTOCRYLENE 9.5 g in 100 g TOPICAL GEL [Orange Gel]


name: HYALURONIC ACID 10 mg in 1 g / RETINOL 10 mg in 1 g / PALMITOYL TETRAPEPTIDE-7 10 mg in 1 g TOPICAL CREAM [LIFT AND FIRM BOOTY MASK]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [Brush On Block Sheer Genius SPF 50 Mineral Moisture Universal Tint]


name: {1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 15 MG / doxylamine succinate 6.25 MG Oral Capsule) } Pack


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL / HOMOSALATE 15 g in 100 mL TOPICAL LOTION [Florida Squeezed SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 6.8 g in 100 g / ZINC OXIDE 8.5 g in 100 g TOPICAL CREAM [BB Noir 30 BS SPF30]


name: OCTOCRYLENE 8.6 g in 100 g / AVOBENZONE 2.9 g in 100 g / HOMOSALATE 6.9 g in 100 g / OCTISALATE 4.9 g in 100 g TOPICAL STICK [Vacation Super]


name: TITANIUM DIOXIDE 6.8 g in 100 g / ZINC OXIDE 8.5 g in 100 g TOPICAL CREAM [BB Blanc 30 BS SPF30]


name: ZINC OXIDE 16 g in 100 mL TOPICAL CREAM [QUARXERY QUARXERY PHYSICAL SUNSCREEN]


name: AVOBENZONE 2.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL / OCTISALATE 4.9 g in 100 mL TOPICAL LOTION [Vacation Instant Browning]


name: BENZALKONIUM CHLORIDE 13 mg in 1 mL TOPICAL SOAP [First Street Dishwashing Concentrate and Antibacterial Hand]


name: ZINC OXIDE 8.5 g in 100 g / TITANIUM DIOXIDE 6.8 g in 100 g TOPICAL CREAM [BB Sienna 30 BS SPF30]


name: AVOBENZONE 2.9 g in 100 mL / OCTOCRYLENE 8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / HOMOSALATE 5 g in 100 mL TOPICAL OIL [Shimmer Oil]


name: HOMOSALATE 5 g in 100 mL / OCTOCRYLENE 8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / AVOBENZONE 2.9 g in 100 mL TOPICAL OIL [Chardonnay Lip Oil]


name: HOMOSALATE 7 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 8 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL AEROSOL, SPRAY [Eucerin Advanced Hydration Sunscreen SPF 30]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Aloe Fresh Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Cotton Fresh Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Double Effect Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Invisible Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Oat Fresh Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Olive Fresh Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM CHLOROHYDRATE 200 mg in 1 mL TOPICAL EMULSION [Babaria Skin Natural Fresh Deodorant and Antiperspirant Liquid Roll-On]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 17 g in 100 g TOPICAL GEL [Gillette ClearShield Fresh Amber Scent Clear]


name: HYALURONIC ACID 1 mg in 1 g / NIACINAMIDE 20 mg in 1 g / TOCOPHEROL 2 mg in 1 g TOPICAL CREAM [Premium Sunscreen Face Stick BULIBIU 50]


name: HYALURONIC ACID 1 mg in 1 g / NIACINAMIDE 20 mg in 1 g / TOCOPHEROL 2 mg in 1 g TOPICAL CREAM [Ultra Sheer moisturizing face serum sunscreen]


name: HYALURONIC ACID 1 mg in 1 g / TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g TOPICAL CREAM [DERMATOLOGIST RECOMMENDED Sport Face oil-free sunscreen]


name: HYALURONIC ACID 1 mg in 1 g / TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g TOPICAL CREAM [sunscreen SUNFORGETTABLE TOTAL PROTECTION FACE SHIELD]


name: NIACINAMIDE 2 mg in 1 g / HYALURONIC ACID 1 mg in 1 g / TOCOPHEROL 2 mg in 1 g TOPICAL CREAM [SINCE 1988 SUNSCREEN 2x Barrier Intensive Cream]


name: NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g / TOCOPHEROL 2 mg in 1 g TOPICAL CREAM [FACE SUNSCREEN HELPS PROTECTS 50 Face BROAD SPECTRUM SPF 50]


name: NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g / TOCOPHEROL 2 mg in 1 g TOPICAL CREAM [PERFECTION FRESH SUNSCREEN Light weight Texture Perfect UV Shield]


name: NIACINAMIDE 20 mg in 1 g / OCTOCRYLENE 40 mg in 1 g / ZINC OXIDE 30 mg in 1 g TOPICAL CREAM [Hydrating Mineral Sunscreen BROAD SPECTRUM SPF 50]


name: NIACINAMIDE 20 mg in 1 g / TOCOPHEROL 2 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [Bulubiu UNSEEN SUNSCREEN SPF 50]


name: OCTISALATE 5 g in 100 g / HOMOSALATE 5 g in 100 g / ZINC OXIDE 9.3 g in 100 g TOPICAL CREAM [Daily Prevention Sheer Matte Moisturizer SPF30]


name: OCTOCRYLENE 40 mg in 1 g / HYALURONIC ACID 1 mg in 1 g / NIACINAMIDE 20 mg in 1 g TOPICAL CREAM [Hydro Boost City Shield water gel sunscreen]


name: OCTOCRYLENE 40 mg in 1 g / NIACINAMIDE 20 mg in 1 g / ZINC OXIDE 30 mg in 1 g TOPICAL CREAM [FACE SUNSCREEN HELPS PROTECTES WATER FIT SUNSERUM]


name: TITANIUM DIOXIDE 2 g in 100 g / ZINC OXIDE 18.4 g in 100 g TOPICAL CREAM [SCENTUAL AROMA BEAUTY SUN VEIL SPF30]


name: TITANIUM DIOXIDE 6.8 g in 100 g / ZINC OXIDE 8.5 g in 100 g TOPICAL CREAM [BB Ambre 30 BS SPF30]


name: TOCOPHEROL 2 mg in 1 g / HYALURONIC ACID 1 mg in 1 g / NIACINAMIDE 20 mg in 1 g TOPICAL CREAM [FACE SUNSCREEN HELPS PROTECTS 50]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [CLEAR SKIN HELPS PROTECTES SUNSCREEN]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [Clear Face BREAKOUT FREE oil-free sunscreen]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [FACE SUNSCREEN Super Light Daily Wrinkle Defense]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [Face Sunscreen 50 BOTANICL TINTED FACE]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [Face Sunscreen SKINCARE UV 50]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [Moisturizing Sunscreen]


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM [PROTECT HYDRATE sunscreen BROAD SPECTRUM UVA UVB PROTECTION]


name: ZINC OXIDE 25 g in 100 mL TOPICAL CREAM [Badger SPF 50 Adventure Sport Mineral Sunscreen Cream]


name: ZINC OXIDE 30 mg in 1 g / NIACINAMIDE 20 mg in 1 g / TOCOPHEROL 2 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL CREAM [Face Sunscreen SKINCARE UV Clear]


name: ALLANTOIN 5 mg in 1 mL TOPICAL GEL [Mederma Advanced]


name: FUROSEMIDE 1 kg in 1 kg NOT APPLICABLE POWDER


name: HYALURONIC ACID 1 mg in 1 g / TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 2 mg in 1 g TOPICAL CREAM [ENJOY SUPER MILD SUN ESSENCE]


name: RETINOL 50 mg in 1 g / ASCORBIC ACID 50 mg in 1 g / TOCOPHEROL 50 mg in 1 g TOPICAL CAPSULE [BULUBIU HAIR VITAMIN]


name: TOCOPHEROL 2 mg in 1 g / HYALURONIC ACID 1 mg in 1 g / NIACINAMIDE 2 mg in 1 g TOPICAL CREAM


name: TOCOPHEROL 2 mg in 1 g / NIACINAMIDE 20 mg in 1 g / HYALURONIC ACID 1 mg in 1 g TOPICAL CREAM


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 16 g in 100 g TOPICAL STICK [Mens Collection Antiperspirant Deodorant Gingham Legend]


name: TITANIUM DIOXIDE 4.7 g in 100 g / ZINC OXIDE 6 g in 100 g TOPICAL CREAM [Daily Prevention Pure Mineral Tinted Moisturizer SPF 30]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [AnYi Beauty Caffeine Eye Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [VOVA 5 Second 2.5% Active Retinol Face Cream]


name: HYPROMELLOSES 0.95 g in 1 g ORAL CAPSULE [Vacant Hypromellose]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [ANYI BEAUTY Kojic Acid Brightening Serum]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [nownoon Retinol 2.5% Face Serum]


name: ZINC OXIDE 15.52 g in 50 mL TOPICAL CREAM [PHYSIOGEL Daily Moisture Therapy Barrier Mineral Sunscreen Broad Spectrum SPF 50]


name: OCTISALATE 5 g in 100 g / OCTOCRYLENE 9.9 g in 100 g / ZINC OXIDE 7 g in 100 g / HOMOSALATE 7.3 g in 100 g TOPICAL CREAM [Daily Prevention Ultra Defense Moisturizer SPF 50]


name: GLYCERIN 8 g in 100 mL TOPICAL LIQUID [AuQuest 24K GOLD NIACINAMIDE ESSENCE]


name: HYDROXYPINACOLONE RETINOATE 5 g in 100 mL TOPICAL LIQUID [JoyPrettyin RETINOL ANTI-WRINKLE SERUM]


name: JOJOBA OIL 10 g in 100 g TOPICAL CREAM [PURC DISULFIDE BOND REDUCTIVE HAIR MASK]


name: NIACINAMIDE 1.8 g in 45 mL / ADENOSINE 0.018 g in 45 mL TOPICAL LIQUID [Subear 4 In 1 Facial Serum]


name: PROPYLENE GLYCOL 5 g in 100 mL TOPICAL CREAM [JoyPrettyin VITAMIN C BRIGHTENING EYE SERUM]


name: ASCORBIC ACID 20 g in 100 mL TOPICAL LIQUID [JoyPrettyin VITAMIN C WHITENING SERUM]


name: CASTOR OIL 100 g in 100 mL TOPICAL OIL [CHANCHI 100 Pure Castor Oil Cold Pressed]


name: COCODIMONIUM HYDROXYPROPYL HYDROLYZED KERATIN (1000 MW) 15 g in 100 g TOPICAL CREAM [PURC 8S REVITALIZES HOT DYEING DAMAGED HAIR MASK]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [CHANCHI Day Night Retinol Collagen Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [CHANCHI Vitamin C Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [NOWNOON Hibiscus Honey Firming Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [NowNoon Retinol Collagen Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Nownoon Day Night Face Lift Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Nownoon Peptides Neck Firmng Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Subear Collagen Day Night Facial Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Subear Collagen Facial Serum]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Subear Hydro Care Face Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Subear Multivitamin Eye Cream]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [Subear Neck Firming Cream]


name: ALUMINUM CHLOROHYDRATE 145 mg in 1 mL TOPICAL STICK [AVON Wild Country Roll-On Anti-Perspirant Deodorant]


name: ALUMINUM CHLOROHYDRATE 207 mg in 1 mL TOPICAL STICK [AVON feelin fresh Original Roll-On Anti-Perspirant Deodorant]


name: OCTOCRYLENE 9.5 g in 100 g / AVOBENZONE 2.9 g in 100 g / OCTISALATE 4.9 g in 100 g TOPICAL SPRAY [Daily Prevention Protect and Refresh Mist SPF 40]


name: ZINC OXIDE 10.5 g in 100 g / TITANIUM DIOXIDE 3.7 g in 100 g TOPICAL CREAM [Daily Prevention Advanced Smartblend Mineral Moisturizer SPF 75]


name: ZINC OXIDE 18.75 g in 100 mL TOPICAL CREAM [Badger SPF 30 Daily Sunscreen]


name: ZINC OXIDE 24.5 g in 100 mL TOPICAL LOTION [Illuminating SPF 50 plus drops Broad Spectrum Sunscreen]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [CHANCHI Intimate Area Radiance Cream]


name: OCTOCRYLENE 100 mg in 1 g / ZINC OXIDE 70 mg in 1 g TOPICAL CREAM [SOLVADERM Dermaxsol Dermal Defense Moisturizer SPF-30]


name: ZINC OXIDE 15.4 g in 100 mL TOPICAL LOTION [Brush On Block Bounce Butter SPF 30 Moisturizing Mousse]


name: Reinforce dressing, as needed (intervention)


name: Using the provided nutritional label how many calories would be consumed if the ate 2 cups of food:Find:Pt:^Patient:Ord


name: CarePoint PRECISION 25G 1-1/2inch Poly-Hub Hypodermic Needle


name: hospitalist outpatient consultation note


name: infectious disease medication management note


name: {4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector) } Pack


name: {6 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector) } Pack


name: angioplasty of abdominal aorta using fluoroscopic guidance


name: {2 (sotatercept-csrk 60 MG Injection [Winrevair]) } Pack [Winrevair 60 MG, 2 Vial Kit]


name: {2 (sotatercept-csrk 45 MG Injection [Winrevair]) } Pack [Winrevair 45 MG, 2 Vial Kit]


name: {90 (danicopan 100 MG Oral Tablet [Voydeya]) / 90 (danicopan 50 MG Oral Tablet [Voydeya]) } Pack [Voydeya 150 MG Dose Bottle]


name: {84 (danicopan 100 MG Oral Tablet [Voydeya]) / 84 (danicopan 50 MG Oral Tablet [Voydeya]) } Pack [Voydeya 150 MG Dose Card]


name: Family members in category group: step, foster, adoptive. Current spouse or romantic partner:Find:Pt:^Patient:Ord


name: Family members in category group: step, foster, adoptive. Daughter(s):Find:Pt:^Patient:Ord


name: Family members in category group: step, foster, adoptive. Brother(s):Find:Pt:^Patient:Ord


name: {14 (cenobamate 12.5 MG Oral Tablet [Xcopri]) } Pack [Xcopri Titration Pack - 12.5 MG 14 Count]


name: Family members in category group: step, foster, adoptive. Father(s):Find:Pt:^Patient:Ord


name: Family members in category group: step, foster, adoptive. Mother(s):Find:Pt:^Patient:Ord


name: Family members in category group: step, foster, adoptive. Sister(s):Find:Pt:^Patient:Ord


name: Family members in category group: step, foster, adoptive. Son(s):Find:Pt:^Patient:Ord


name: Family members you feel close with held in a jail or prison for a night or more at some point in their lives:Find:Pt:^Patient:Ord


name: Feels lonely, unwanted, or unloved; complains that no one loves him or her:Find:6Mo:^Patient:Ord


name: Feels worthless or inferior:Find:6Mo:^Patient:Ord


name: Fidgets with hands or feet or squirms in seat:Find:6Mo:^Patient:Ord


name: Was blood drawn successfully:Find:Pt:^Patient:Ord


name: Was blood requested for lipid profile:Find:Pt:^Patient:Ord


name: Were bench quality control specimens used at the beginning of each analystical run


name: Were bench quality control specimens used at the beginning of each analystical run:Find:Pt:^Patient:Ord


name: Were lipemic specimens clarified by centrifugation at about 15,000g prior to testing:Time:Pt:^Patient:Qn


name: Were lipemic specimens clarified by centrifugation at about 15,000g prior to testing


name: Were specimens maintained at 20-25 degrees celsius during tesing and stored at -70 degrees celsius or lower after testing:Find:Pt:^Patient:Ord


name: Were specimens maintained at 20-25 degrees celsius during tesing and stored at -70 degrees celsius or lower after testing


name: Were the calibration standard dilutions used within 4 hours of preparation


name: Were the calibration standard dilutions used within 4 hours of preparation:Find:Pt:^Patient:Ord


name: Were the CardioPhase, Rheumatology, and Supplementary reagents stored between 4-8 degrees Celsius and never frozen:Find:Pt:^Patient:Ord


name: Were the CardioPhase, Rheumatology, and Supplementary reagents stored between 4-8 degrees Celsius and never frozen


name: Were the Diluent and Rx buffer reagents stored at room temperature


name: Were the Diluent and Rx buffer reagents stored at room temperature:Find:Pt:^Patient:Ord


name: Were the QC materials stored at -20 degrees Celsius or colder before being thawed and stored at 2-8 degrees Celsius and used within 30 days


name: Were the QC materials stored at -20 degrees Celsius or colder before being thawed and stored at 2-8 degrees Celsius and used within 30 days:Find:Pt:^Patient:Ord


name: Were the temperatures of the controls and patient specimens brought up to room temperature before use


name: Were the temperatures of the controls and patient specimens brought up to room temperature before use:Find:Pt:^Patient:Ord


name: Were the three levels of control ran for each test series and did not conform to quality control manual specifications


name: Were the three levels of control ran for each test series and did not conform to quality control manual specifications:Find:Pt:^Patient:Ord


name: Who completed this form:Find:Pt:^Patient:Ord


name: SP100 and GP210 Antibody.immunoglobulin G panel


name: SP100 and GP210 Ab.IgG panel:-:Pt:Ser/Plas:-


name: Specimens stored at -20 degrees Celsius or cooler:Find:Pt:^Patient:Ord


name: allergy and immunology medication management note


name: fluoroscopic angiography and thrombolysis of aorta and femoral artery


name: fluoroscopic angiography and thrombolysis of femoral artery


name: fluoroscopic angiography and thrombolysis of lower limb artery


name: percutaneous mechanical thrombectomy of pulmonary vein using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of mesenteric artery using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of superior vena cava using fluoroscopic guidance


name: percutaneous transluminal revascularization of chronic total occlusion of coronary artery using fluoroscopic guidance


name: For temperature above 102.5 F. go to the hospital and for temperatures below 102.5 F. take tylenol and rest:Find:Pt:^Patient:Ord


name: Has a doctor or nurse ever said that you have high blood cholesterol:Find:Pt:^Patient:Ord


name: Has a doctor or nurse ever said that you have high blood cholesterol


name: Has broken into someone else's home, business, or car:Find:6Mo:^Patient:Ord


name: Has deliberately set fires to cause damage:Find:6Mo:^Patient:Ord


name: Has difficulty keeping attention to what needs to be done:Find:6Mo:^Patient:Ord


name: Has difficulty organizing tasks and activities:Find:6Mo:^Patient:Ord


name: Has difficulty playing or beginning quiet play activities:Find:6Mo:^Patient:Ord


name: Has difficulty waiting his or her turn:Find:6Mo:^Patient:Ord


name: Has forced someone into sexual activity:Find:6Mo:^Patient:Ord


name: Has run away from home overnight:Find:6Mo:^Patient:Ord


name: Has stayed out at night without permission:Find:6Mo:^Patient:Ord


name: Have you ever taken medication for high blood cholesterol:Find:Pt:^Patient:Ord


name: HDL from lipid profile:Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Anyone else you have had a child with:Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Brother(s):Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Current spouse or romantic partner:Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Daughter(s):Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Father(s):Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Mother(s):Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Sister(s):Find:Pt:^Patient:Ord


name: Held in jail or prison one night or longer. step, foster, and adoptive family members. Son(s):Find:Pt:^Patient:Ord


name: How easy would it be for you to find a job:Find:Pt:^Patient:Ord


name: How easy would it be for you to find a job


name: How much time is usually spent on screens


name: How much time is usually spent on screens:NRat:Pt:^Patient:Qn


name: How often would you were worried or stressed about paying for rent or mortgage, past 12Mo


name: How often would you were worried or stressed about paying for rent or mortgage, past 12Mo:Find:12Mo:^Patient:Nom


name: Hyperactivity or impulsivity score:Score:6Mo:^Patient:Qn


name: If someone else, what is person's relationship to the person named on the front of this form


name: If someone else, what is person's relationship to the person named on the front of this form:Find:Pt:^Patient:Ord


name: The chance of a serious side effect of a new blood pressure medication is 0.5% so what is the number that is expected to have a serious side effect:Find:Pt:^Patient:Ord


name: The chance of a serious side effect of a new blood pressure medication is 0.5% so what is the number that is expected to have a serious side effect


name: The chance of having a heart attack increases as people age and if they smoke and the chance of a heart attack increases 10% over the next 10 years:Find:Pt:^Patient:Ord


name: Medicaid State-sponsored Children's Health Insurance Program Plan


name: Home Oxygen Therapy Use Duration Indicator


name: bone marrow transplant medication management note


name: cardiology outpatient rehabilitation note


name: vascular access history and physical note


name: Has stolen things that have value:Find:6Mo:^Patient:Ord


name: Has used a weapon that can cause serious harm (bat, knife, brick, gun):Find:6Mo:^Patient:Ord


name: Have you ever taken medication for high blood cholesterol


name: 30M after maximum clot amplitude post heparin neutralization


name: 90 percent of daily air quality index (AQI) values:Num:Pt:^Patient:Qn


name: A medical study will randomly assign equally medicine A or medicine B to 300 people about how many are expected to get medicine A


name: A medical study will randomly assign equally medicine A or medicine B to 300 people about how many are expected to get medicine A:Find:Pt:^Patient:Ord


name: A patient was given a new medicine and handout showing the chance of the side effects will occur and the side effects that the patient will least likely to get:Find:Pt:^Patient:Ord


name: A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%:Find:Pt:^Patient:Ord


name: Actively defies or refuses to go along with adults' requests or rules:Find:6Mo:^Patient:Ord


name: Immunoglobulin light chains.free panel:-:Pt:Ser/Plas:-


name: Inattention and hyperactivity or impulsivity score:Score:6Mo:^Patient:Qn


name: Information updated date and time:TmStp:Pt:^Patient:Qn


name: Interrupts or intrudes in on others' conversations or activities:Find:6Mo:^Patient:Ord


name: Is afraid to try new things for fear of making mistakes:Find:6Mo:^Patient:Ord


name: Is angry or resentful:Find:6Mo:^Patient:Ord


name: Is easily distracted by noises or other stimuli:Find:6Mo:^Patient:Ord


name: Is fearful, anxious, or worried:Find:6Mo:^Patient:Ord


name: Is forgetful in daily activities:Find:6Mo:^Patient:Ord


name: Is on the go or often acts as if driven by a motor:Find:6Mo:^Patient:Ord


name: Is physically cruel to animals:Find:6Mo:^Patient:Ord


name: Is physically cruel to people:Find:6Mo:^Patient:Ord


name: Is sad, unhappy, or depressed:Find:6Mo:^Patient:Ord


name: Is self-conscious or easily embarrassed:Find:6Mo:^Patient:Ord


name: Is spiteful and wants to get even:Find:6Mo:^Patient:Ord


name: Is the lowest reportable value at least 0.02 mg per dL:Find:Pt:^Patient:Ord


name: Is the lowest reportable value at least 0.02 mg per dL


name: Is the sample volume at least 0.3 mL:Find:Pt:^Patient:Ord


name: Is this evaluation based on a time when the child


name: Is this evaluation based on a time when the child:Find:6Mo:^Patient:Ord


name: The Level of health numeracy score number shows the chance of having a cancer medication side effect:Find:Pt:^Patient:Ord


name: The number of convenience stores in the county:Num:Pt:^Patient:Qn


name: The number of limited-service restaurants in the county:Num:Pt:^Patient:Qn


name: Thinking about the next 12Mo, how likely do you think you will lose your job or be laid off:Find:12Mo:^Patient:Ord


name: Thinking about the next 12Mo, how likely do you think you will lose your job or be laid off


name: child and adolescent psychiatry outpatient note


name: lambda lymphocytes/100 lymphocytes in bone marrow


name: long term care facility medication management note


name: mental health outpatient consultation note


name: percutaneous transluminal angioplasty of hepatic artery using fluoroscopic guidance


name: percutaneous transluminal cutting balloon angioplasty of hepatic artery using fluoroscopic guidance


name: revision of percutaneous transluminal coil embolization of cerebral aneurysm using fluoroscopic guidance


name: Adverse reaction event summary:Find:Pt:^Patient:Nar


name: Age at which you began taking medicine for this:Time:Pt:^Patient:Qn


name: Is touchy or easily annoyed by others:Find:6Mo:^Patient:Ord


name: Is truant from school (skips school) without permission:Find:6Mo:^Patient:Ord


name: Laboratory test details panel:-:Pt:^Patient:-


name: LDL from lipid profile:Find:Pt:^Patient:Ord


name: Leaves seat when remaining seated is expected:Find:6Mo:^Patient:Ord


name: Lies to get out of trouble or to avoid obligations (ie cons others):Find:6Mo:^Patient:Ord


name: Likelihood that a new diabetic medicine that led to blood sugar control in 8% more patients than the old diabetic medicine was due to chance alone:Find:Pt:^Patient:Ord


name: Location end date and time:Date:Pt:^Patient:Qn


name: Location start date and time:Date:Pt:^Patient:Qn


name: Longest amount of time family members spent in jail or prison:Time:Pt:^Patient:Ord


name: Loses things necessary for tasks or activities (toys, assignments, pencils, or books):Find:6Mo:^Patient:Ord


name: Time blood drawn for lipid profile:TmStp:Pt:^Patient:Qn


name: Total cholesterol from lipid profile:Find:Pt:^Patient:Ord


name: Traffic proximity and volume:NFr:Pt:^Patient:Qn


name: Triglycerides from lipid profile:Find:Pt:^Patient:Ord


name: occlusion of large intestine (treatment)


name: Alcoholic drinks per W:NRat:Pt:^Patient:Qn


name: Allergy last occurance date:Date:Pt:^Patient:Qn


name: Anxiety or depression score:Score:6Mo:^Patient:Qn


name: Are the dilution wells empty:Find:Pt:^Patient:Ord


name: Are the specimens stored in glass or plastic vials


name: Are the specimens stored in glass or plastic vials:Find:Pt:^Patient:Ord


name: Arthritis study in patients found that medicine A decreased arthritis pain 10% more often than medicine B:Find:Pt:^Patient:Ord


name: Associated sign and symptom:Find:Pt:^Patient:Nom


name: Maximum air quality index (AQI):Num:Pt:^Patient:Qn


name: Maximum number of administrations:Num:Pt:^Patient:Qn


name: Measles, mumps, rubella and varicella-zoster virus Ab.IgG panel


name: Measles, mumps, rubella and varicella-zoster virus Ab.IgG panel:-:Pt:Ser/Plas:-


name: Mechanical circulatory support+diagnostic study report:Find:Pt:{Setting}:Doc


name: Mechanical circulatory support+diagnostic study report


name: Medication cessation date time:Date:Pt:^Patient:Qn


name: Medication safety override reason:Find:Pt:^Patient:Nom


name: Men who are tested for prostate cancer using the PSA (prostate specific antigen) test, about 30% who have an abnormal PSA turn out not to have cancer:Find:Pt:^Patient:Ord


name: percutaneous brachytherapy of hepatic artery using fluoroscopic guidance


name: other cells/100 leukocytes in bronchoalveolar lavage by manual count


name: physical medicine and rehab outpatient consultation note


name: physical therapy outpatient evaluation note


name: Associated sign or symptom:Find:Pt:^Patient:Nom


name: At what age did you begin taking medicine for this:Time:Pt:^Patient:Qn


name: At what age did you begin taking medicine for this


name: Avoids, dislikes, or does not want to start tasks that require ongoing mental effort:Find:6Mo:^Patient:Ord


name: Bacterial antimicrobial resistance CFR gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaZ gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Blames others for his or her mistakes or misbehaviors:Find:6Mo:^Patient:Ord


name: Blames self for problems, feels guilty:Find:6Mo:^Patient:Ord


name: Blurts out answers before questions have been completed:Find:6Mo:^Patient:Ord


name: Multisection cine for blood flow velocity mapping^WO contrast IV:Find:Pt:Chest>Heart:Doc:MR


name: Multisection^WO contrast IV:Find:Pt:Pelvis>Lumbosacral plexus:Doc:MR


name: Multisection^WO contrast IV:Find:Pt:Abdomen>Abdominal veins:Doc:MR.angio


name: Multisection^WO contrast IV:Find:Pt:Head>Head vessels & Neck>Neck vessels:Doc:MR.angio


name: Multisection:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:MR.angio


name: Multisection^WO contrast IV:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:MR.angio


name: Multisection^WO contrast IV:Find:Pt:Upper extremity.left>Upper extremity vessels:Doc:MR.angio


name: Multisection^WO contrast IV:Find:Pt:Upper extremity.right>Upper extremity vessels:Doc:MR.angio


name: National scale air toxics assessment air toxics cancer risk


name: National scale air toxics assessment air toxics cancer risk:NFr:Pt:^Patient:Qn


name: National scale air toxics assessment diesel PM (DPM)


name: National scale air toxics assessment diesel PM (DPM):NFr:Pt:^Patient:Qn


name: National scale air toxics assessment respiratory hazard index:NFr:Pt:^Patient:Qn


name: National scale air toxics assessment respiratory hazard index


name: Neutrophil Ab screen panel:-:Pt:Ser/Plas:-


name: NICHQ Vanderbilt Assessment Scale - Parent Informant:-:6Mo:^Patient:-


name: NICHQ Vanderbilt Assessment Scale - Parent Informant


name: rapid response team history and physical note


name: Bullies, threatens, or intimidates others:Find:6Mo:^Patient:Ord


name: Calcium oxalate crystals:PrThr:Pt:Urine sed:Ord:Microscopy


name: Care plan request information:Type:Pt:^Patient:Nom


name: Care plan requested activity information:Txt:Pt:^Patient:Nom


name: Care plan requested activity information


name: Chance of surviving 3 years after breast cancer diagnosis:Find:Pt:^Patient:Ord


name: No harm related to unintentional sterile field/wound contamination:Find:Pt:^Patient:Ord


name: Number of affected family members:Num:Pt:^Patient:Qn


name: Number of days carbon monoxide:Time:Pt:^Patient:Qn


name: Number of days having an air quality index value (AQI):Time:Pt:^Patient:Qn


name: Number of D having an AQI value 0 through 50:Time:Pt:^Patient:Qn


name: Number of D having an AQI value 101 through 150:Time:Pt:^Patient:Qn


name: Number of D having an AQI value 151 through 200:Time:Pt:^Patient:Qn


name: Number of D having an AQI value 201 or higher:Time:Pt:^Patient:Qn


name: Number of D having an AQI value 51 through 100:Time:Pt:^Patient:Qn


name: Number of days nitrogen dioxide:Time:Pt:^Patient:Qn


name: Number of days ozone:Time:Pt:^Patient:Qn


name: Number of days particulate matter10:Time:Pt:^Patient:Qn


name: Number of days particulate matter2.5:Time:Pt:^Patient:Qn


name: Number of days sulphur dioxide:Time:Pt:^Patient:Qn


name: Number of patients who have stage 2 breast cancer the chance that the breast cancer will come back is 10% over the next 10Y:Find:Pt:^Patient:Ord


name: Number of supermarkets and grocery stores in the county:Num:Pt:^Patient:Qn


name: Ongoing problem episode reason:Find:Pt:^Patient:Nar


name: Clinical decision support for ICU discharge:Type:Pt:^Patient:Nom


name: Clinical decision support for ICU discharge


name: Cobalamin, Methionine & Methylmalonic Acid Pathways Panel


name: Cobalamin, Methionine & Methylmalonic Acid Pathways Panel:-:Pt:Ser/Plas:-


name: Communication capability information panel:-:Pt:^Patient:-


name: Communication capability information panel


name: Condition certainty of absence:Find:Pt:^Patient:Nom


name: Confidentially and for statistical purposes only, have any members of your immediate family NOT including yourself, ever been held in jail or prison for one night or longer:Find:Pt:^Patient:Ord


name: Confidentially and for statistical purposes only, have any members of your immediate family NOT including yourself, ever been held in jail or prison for one night or longer


name: Order to not take more than 3 grams of Tylenol and each Tylenol pill is 500 milligrams (mg) the highest number of pills can be taken in 1d:Find:Pt:^Patient:Ord


name: Ovarian malignancy (ROMA) panel:-:Pt:Ser/Plas:-


name: Participation in organized activities (eg, teams)


name: Participation in organized activities (eg, teams):Find:6Mo:^Patient:Ord


name: Patient has a pain rating of 5 on a pain scale of 1 (no pain) to 10 (worst possible pain), pain has improved 1D later, now, what pain rating might the patient have:Find:Pt:^Patient:Ord


name: Patient has a pain rating of 5 on a pain scale of 1 (no pain) to 10 (worst possible pain), pain has improved 1D later, now, what pain rating might the patient have


name: Percentage blockage with highest chance of a heart attack:Find:Pt:^Patient:Ord


name: Percentage of a block group's population in households where the household income is less than or equal to twice the federal poverty level:NFr:Pt:^Patient:Qn


name: Percentage of adults in the 40-49 year old age group with diabetes:Num:Pt:^Patient:Qn


name: Percentage of individuals in a block group who list their racial status as a race other than white alone and or list their ethnicity as Hispanic or Latino:NFr:Pt:^Patient:Qn


name: Percentage of people aged 25 or older in a block group whose education is short of a high school diploma:NFr:Pt:^Patient:Qn


name: Percentage of people in a block group living in linguistically isolated households:NFr:Pt:^Patient:Qn


name: Percentage of people in a block group older than age 64:NFr:Pt:^Patient:Qn


name: speech-language pathology outpatient note


name: clinical cardiac electrophysiology surgical operation note


name: Creatine, guanidinoacetate & creatinine panel:-:Pt:Ser/Plas:-


name: Date and time of condition resolution:TmStp:Pt:^Patient:Qn


name: Date and time of last update of data:Date:Pt:^Patient:Qn


name: Date blood drawn for lipid profile:Date:Pt:^Patient:Qn


name: Deliberately destroys others' property:Find:6Mo:^Patient:Ord


name: Dengue virus Ab.IgG & IgM & NS1 Ag panel


name: Dengue virus Ab.IgG & IgM & NS1 Ag panel:-:Pt:Ser/Plas:-


name: Device fitting or implant status:Find:Pt:^Patient:Nom


name: Device identifier of unspecified type:ID:Pt:^Patient:Nom


name: Percentage of people in a block group younger than age 5:NFr:Pt:^Patient:Qn


name: PhenX - access health services last seen doctor protocol 270101:-:Pt:^Patient:-:PhenX


name: PhenX - access health services last seen doctor protocol 270101


name: PhenX - air quality index protocol 290101


name: PhenX - air quality index protocol 290101:-:Pt:^Patient:-:PhenX


name: PhenX - C reactive protein (CRP) protocol 660601:-:Pt:^Patient:-:PhenX


name: PhenX - C reactive protein (CRP) protocol 660601


name: PhenX - environmental justice protocol 290401


name: PhenX - environmental justice protocol 290401:-:Pt:^Patient:-:PhenX


name: PhenX - family history of incarceration protocol 281001:-:Pt:^Patient:-:PhenX


name: PhenX - family history of incarceration protocol 281001


name: PhenX - food swamp protocol 290501:-:Pt:^Patient:-:PhenX


name: PhenX - health numeracy protocol 280201:-:Pt:^Patient:-:PhenX


name: PhenX - healthcare communications protocol 281101


name: PhenX - healthcare communications protocol 281101:-:Pt:^Patient:-:PhenX


name: PhenX - housing instability due to affordability 281201


name: PhenX - housing instability due to affordability 281201:-:Pt:^Patient:-:PhenX


name: PhenX - job insecurity protocol 280301:-:Pt:^Patient:-:PhenX


name: PhenX - lipid profile protocol 40201:-:Pt:^Patient:-:PhenX


name: Phenx - Occupational prestige protocol 270501:-:Pt:^Patient:-:PhenX


name: Phenx - Occupational prestige protocol 270501


name: Primary biliary cholangitis comprehensive Ab panel


name: comprehensive foot screening report document


name: critical care medicine medication management note


name: electrochemiluminescence immunoassay of beta-amyloid and total tau in cerebrospinal fluid for amyloid pathology


name: electrochemiluminescent immunoassay of beta-amyloid and phospho-tau in CSF for amyloid pathology


name: emergency medicine medication management note


name: endocrinology medication management note


name: Device review due date:Date:Pt:^Patient:Qn


name: Diabetes mellitus type 1 autoimmune panel


name: Diabetes mellitus type 1 autoimmune panel:-:Pt:Ser/Plas:-


name: Diabetic patient's goal is to have his blood sugar between 80 and 150 in the morning:Find:Pt:^Patient:Ord


name: Do you own or rent your home:Find:Pt:^Patient:Ord


name: Does not follow through when given directions and fails to finish activities (not due to refusal or failure to understand):Find:6Mo:^Patient:Ord


name: Does not pay attention to details or makes careless mistakes with, for example, homework:Find:6Mo:^Patient:Ord


name: Does not seem to listen when spoken to directly:Find:6Mo:^Patient:Ord


name: Drinks of water per D:NRat:Pt:^Patient:Qn


name: Driver license medical fitness certificate


name: Driver license medical fitness certificate:Find:Pt:{Setting}:Doc:{Role}


name: Primary biliary cholangitis comprehensive Ab panel:-:Pt:Ser/Plas:-


name: Problem family prevalence details:Pn:Pt:^Patient:Nom


name: Problem level of control:Find:Pt:^Patient:Nar


name: Procedure end date and time:TmStp:Pt:^Patient:Qn


name: Proof of medical test certificate:Find:Pt:{Setting}:Doc:{Role}


name: Proximity to major direct water dischargers


name: Proximity to major direct water dischargers:NFr:Pt:^Patient:Qn


name: Proximity to national priorities list sites:NFr:Pt:^Patient:Qn


name: Proximity to national priorities list sites


name: Proximity to risk management plan sites:NFr:Pt:^Patient:Qn


name: Proximity to treatment storage and disposal facilities:NFr:Pt:^Patient:Qn


name: Proximity to treatment storage and disposal facilities


name: gastroenterology outpatient consultation note


name: Estimated body mass index 50th percentile for age:Prctl:Pt:^Patient:Qn


name: Results of a randomized controlled trial will be more reliable if a larger number of people are in the study:Find:Pt:^Patient:Ord


name: Rheumatoid Factor IgM and IgA antibody panel:-:Pt:Ser/Plas:-


name: Rheumatoid Factor IgM and IgA antibody panel


name: Runs about or climbs too much when remaining seated is expected:Find:6Mo:^Patient:Ord


name: Serum or plasma separated within 60 minutes of collection:Find:Pt:^Patient:Ord


name: general medicine preoperative evaluation and management note


name: Children of Women Vietnam Veterans Health Care Benefits Program


name: Program of All-Inclusive Care for the Elderly (PACE)


name: Plasmin Alpha-2 Antiplasmin Complex Measurement


name: Severe acute respiratory syndrome coronavirus main protease inhibitor (disposition)


name: Neurokinin 3 receptor antagonist (disposition)


name: encounter for sepsis aftercare (treatment)


name: {4 (apremilast 10 MG Oral Tablet [Otezla]) / 23 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 14-Day 10/20 Starter Pack]


name: percutaneous mechanical thrombectomy of cerebral venous sinus using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of hepatic vein using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of inferior vena cava using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of mesenteric vein using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of portal vein using fluoroscopic guidance


name: percutaneous mechanical thrombectomy of pulmonary artery using fluoroscopic guidance


name: T-Cell Surface Glycoprotein CD5 Measurement


name: Molecular Characterization Initiative for Childhood Cancers


name: Medroxyprogesterone Alternating with Tamoxifen Regimen


name: Health Maintenance Organization Point of Service Plan


name: SARS coronavirus main proteinase inhibitor


name: Screening for malignant neoplasm of oral cavity


name: PLZ4-coated Paclitaxel-loaded Micelle Formulation


name: Cornell Assessment of Pediatric Delirium


name: {14 (nirogacestat 150 MG Oral Tablet [Ogsiveo]) } Pack [Ogsiveo 150 MG 7-Day]


name: {7 (1 ML fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection [Beqvez]) } Pack [Beqvez Kit 115 - 135 KG]


name: {6 (1 ML fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection [Beqvez]) } Pack [Beqvez Kit 95 - 115 KG]


name: {5 (1 ML fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection [Beqvez]) } Pack [Beqvez Kit 75 - 95 KG]


name: {4 (1 ML fidanacogene elaparvovec-dzkt 10000000000000 VECTOR-GENOMES/ML Injection [Beqvez]) } Pack [Beqvez Kit < 75 KG]


name: Endoscopic coagulation of hemorrhage of small intestine


name: Therapeutic transfusion of convalescent plasma


name: {14 (nirogacestat 100 MG Oral Tablet [Ogsiveo]) } Pack [Ogsiveo 100 MG 7-Day]


name: {4 (apremilast 10 MG Oral Tablet [Otezla]) / 51 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20 Starter Pack]


name: Family members in category group: step, foster, adoptive. Anyone else you have had a child with:Find:Pt:^Patient:Ord


name: {4 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.4 ML Starter Pack - Psoriasis]


name: {6 (0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.4 ML Starter Pack - Crohn's Disease or Ulcerative Colitis]


name: Daytime Nighttime Severe Cold and Flu KIT


name: {7 (24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 18 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 24 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 30 MG Extended Release Oral Tablet [Austedo]) } Pack [Austedo XR Once Daily, 4 Week Titration Pack, 12 MG / 18 MG / 24 MG / 30 MG]


name: HUGO Gene Nomenclature Committee, 2024_04


name: 18F fluoro-DOPA positron emission tomography


name: Hormonal contraceptive implant insertion


name: Sagittal split mandibular ramus osteotomy


name: Laparoscopic resection of pelvic schwannoma


name: Dental cone beam computerised tomography


name: Percutaneous transluminal angioplasty of arteriovenous fistula


name: Hydroxy-methylglutaryl-coenzyme A reductase test


name: Marking of axillary lymph node with radioactive iodine seeds


name: VTSL National Animal Health Laboratory Network age related groupings reference set


name: inhibition of host adaptive immune response by virus


name: disruption by virus of host JAK-STAT cascade


name: down-regulation by virus of host JAK-STAT cascade


name: inhibition by virus of host mRNA nuclear export


name: inhibition by virus of host mRNA processing


name: disruption by virus of host TRAF-mediated signal transduction


name: disruption by virus of host JAK-STAT cascade via inhibition of host IRF9 activity


name: disruption by virus of host JAK-STAT cascade via inhibition of STAT activity


name: disruption by virus of host JAK-STAT cascade via inhibition of STAT1 activity


name: disruption by virus of host JAK-STAT cascade via inhibition of STAT2 activity


name: disruption by virus of host JAK-STAT cascade via inhibition of host TYK2 activity


name: disruption by virus of host JAK-STAT cascade via inhibition of JAK1 activity


name: negative regulation by virus of host JAK


name: suppression by virus of host JAK1 activity


name: perturbation by virus of G2/M transition of host mitotic cell cycle


name: perturbation by virus of host exit from mitosis


name: symbiont-mediated degradation of host mRNA


name: inhibition of host transcription initiation by virus


name: viral inhibition of cellular protein synthesis


name: perturbation by virus of host G1/S transition checkpoint


name: perturbation by virus of host G0/G1 transition checkpoint


name: viral inhibition of termination of host cell protein biosynthesis


name: inhibition of host MHC class I molecule presentation by virus


name: negative regulation by virus of MHC class I cell surface presentation


name: positive regulation by virus of host apoptosis


name: negative regulation by virus of host interferon-mediated signaling pathway


name: transforming growth factor beta receptor superfamily signaling pathway


name: phospholipase C-activating endothelin receptor signaling pathway


name: CDISC Questionnaire PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Test Name Terminology


name: CDISC Questionnaire PROMIS Item Bank Version 2.0 Cognitive Function Short Form 6a Test Code Terminology


name: CDISC Questionnaire PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Test Name Terminology


name: CDISC Questionnaire PROMIS Item Bank Version 1.0 Fatigue Short Form 7a Test Code Terminology


name: CDISC Clinical Classification Minnesota Tobacco Withdrawal Scale-Revised Test Name Terminology


name: CDISC Clinical Classification Minnesota Tobacco Withdrawal Scale-Revised Test Code Terminology


name: CDISC Clinical Classification Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Original Response Terminology


name: CDISC Clinical Classification Minnesota Tobacco Withdrawal Scale-Revised MTWSR101 Through MTWSR115 Standardized Character Response Terminology


name: CDISC SDTM London Deauville Criteria Point Scale 2014 Response Terminology


name: CDISC MRCT Center Clinical Research Glossary


name: Selective Estrogen Receptor Covalent Antagonist


name: CDISC Questionnaire Perianal Crohn's Disease Activity Index Test Name Terminology


name: CDISC Questionnaire Perianal Crohn's Disease Activity Index Test Code Terminology


name: CDISC Questionnaire Penn State Electronic Cigarette Dependence Index Test Name Terminology


name: CDISC Questionnaire Penn State Electronic Cigarette Dependence Index Test Code Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27th March 2024 Version Test Name Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27th March 2024 Version Test Code Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0101 Original Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0101 Standardized Character Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0102 Original Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0102 Standardized Character Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0103 Original Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0104 Original Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0104 Standardized Character Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0105 Original Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0105 Standardized Character Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0106 Original Response Terminology


name: CDISC Clinical Classification Sepsis-related Organ Failure Assessment 27MAR2024 SOFA0106 Standardized Character Response Terminology